When the patient arrives with the answer: AI and the doctor–patient relationship
AI has ended medicine’s monopoly on medical information. It has not ended the need for medical judgment.
Read the issueNewsletter
One question at a time: what the evidence supports, where it is still uncertain, and what it means in practice.
The perspective is that of an operator, not a commentator. I am interested in ideas that survive contact with real organisations, clients, teams, budgets and constraints.
I read forty to fifty books per year across different disciplines, because the best ideas usually come from outside one’s own field, and I publish what I learn, including the failures, because growth happens in communities built on openness.
The newsletter is organised around seven recurring themes.
Why we age: the hallmarks of ageing, senolytics, stem cells, genetics and epigenetics — what the biology actually says.
Longevity medicine, diagnostics, biomarkers, AI and the changing relationship between doctor and patient.
What the evidence supports on diet, fasting and what is on the plate — without miracle molecules.
Strength, cardio fitness, VO₂ max and flexibility: the most reliable levers we have.
Sleep, stress, meditation and the mind — the pillar that quietly supports the others.
Interviews with the researchers and clinicians who do the work.
Why longevity matters, the longevity economy and where all of this is going.
Subscribe
Longevity is moving quickly. The problem is not a lack of information but too much information with too little hierarchy.
Each issue starts with one question, reviews what the evidence supports, identifies the uncertainty and ends with the practical implications. Many issues are conversations with the researchers and clinicians who do the work.
Subscribe to Unlock LongevityRead the latest issue
Unlock Longevity is for general information only and does not provide medical advice.
Archive
AI has ended medicine’s monopoly on medical information. It has not ended the need for medical judgment.
Read the issueWhat sustained stress does to the body over decades, and which counter-measures have evidence behind them.
Read the issueTraditional medicine waits for disease; longevity medicine looks for risk. Where the difference shows in practice.
Read the issueTwo pillars that are easy to preach and hard to practise, and what the evidence says they are worth.
Read the issueBowhead whales, naked mole-rats and what comparative biology suggests about our own limits.
Read the issueWhere AI genuinely improves prevention and diagnosis, and where the human remains irreplaceable.
Read the issueFour words used interchangeably that mean very different things. Getting them straight changes the goal.
Read the issueThe science of senescent cells, and how far senolytic therapies really are from everyday medicine.
Read the issueThe doses and mixes of movement with the strongest evidence for added healthy years.
Read the issueThe measurements worth repeating over time, and the ones that are mostly noise.
Read the issueThe unglamorous routines that carry most of the result.
Read the issueWhat twin studies and epigenetics say about how much is actually in our hands.
Read the issueThe leading theories of ageing, and the honest state of reversal research.
Read the issueThe first of a series answering the questions I am asked most often, on stages and at dinner tables.
Read the issueThe plan for 2026: one reader question per issue, answered with evidence.
Read the issueWhat a year of writing taught me about the questions readers actually have.
Read the issueWhere personalised prevention is heading, and what it will demand of clinics and clients alike.
Read the issueDifferent organs age at different speeds. What organ-specific ageing clocks reveal.
Read the issueHow personalised formulations work, and where the line between craft and evidence runs.
Read the issueWhat a major review of diet research actually supports, beyond the headlines.
Read the issueVirtual models of a patient, fed by their own biology, and what they could do for prevention.
Read the issueWith Filippo Ongaro, former ESA doctor, on what space medicine teaches about ageing well.
Read the issueGrowth, achievement, rediscovery, legacy. Why midlife is a transition rather than an ending, after Avivah Wittenberg-Cox.
Read the issueA new architecture of assessment: measure first, intervene second, follow up always.
Read the issueOn the early but intriguing evidence around low-dose lithium and the ageing brain.
Read the issueWhat we know about microplastics in the body, and which exposures can realistically be reduced.
Read the issueThe overlooked third pillar of movement, and why range of motion predicts independence.
Read the issueWhy cardiorespiratory fitness is one of the strongest predictors of lifespan we have.
Read the issueMuscle as an organ of longevity: strength, frailty and what to do about both.
Read the issueWith the molecular biologist on cellular senescence, DNA damage and what they mean for ageing.
Read the issueWhat VO₂ max measures, why it matters so much, and how to improve it.
Read the issueOn anticipating the science that will shape the next twenty-five years.
Read the issuePart two with Professor Stefan Catsicas, on turning laboratory science into investable innovation.
Read the issueWith Professor Stefan Catsicas on how serious science finds its way to patients and investors.
Read the issueWhat “ultra-processed” actually means, and how much it matters.
Read the issueLife expectancy differs by 33 years between countries. What drives the gap, and what could close it.
Read the issueA tour of the research areas most likely to change how we age.
Read the issueCold exposure between fashion and physiology: what the evidence actually supports.
Read the issueWhy capital is moving into longevity, and how to tell substance from vocabulary.
Read the issueSmall, sustainable changes at the table and their measurable returns.
Read the issueWhat hospitality can teach medicine about how care is experienced.
Read the issueBeliefs about ageing shape behaviour, and behaviour shapes biology.
Read the issueWhat the newest layers of biological measurement can see that standard tests cannot.
Read the issueFresh evidence on the balance between what we inherit and what we do.
Read the issueWhat fasting protocols can and cannot deliver, beyond the enthusiasm.
Read the issueWith Dr Serge Rezzi on which supplements have evidence behind them, and which are marketing.
Read the issueThe final part of a three-part guide to the biological mechanisms of ageing.
Read the issuePart two of a three-part guide to the biological mechanisms of ageing.
Read the issuePart one of a three-part guide to the biological mechanisms of ageing.
Read the issueThe measurable physiology of human touch in care.
Read the issueWhat stem-cell science can honestly promise today, and what remains hope.
Read the issueThe foods and eating patterns with real evidence for the brain.
Read the issueWhy protecting cognition is the heart of healthy ageing.
Read the issueWith Dr Adrian Heini on what classic clinical markers still tell us.
Read the issueWith Dr Justin Carrard on training intensity, HIIT and long-term health.
Read the issueOn the recurring dream of a single fix, and why the answer is a system.
Read the issueGenetics sets a ceiling; how we live decides how close we get to it.
Read the issueWhy no single molecule has earned the name, and what works instead.
Read the issueThe habit that changed my own mornings, and what it does measurably.
Read the issueThe slow fire behind most age-related disease, and how to lower it.
Read the issueBehind the scenes of an assessment week: what is measured, and why.
Read the issueThe argument for treating healthy years, not years alone, as the goal.
Read the issueWhy I started this newsletter, and what to expect from it.
Read the issueIssues open on LinkedIn, where the newsletter is currently published. Reading times and review notes will be added as issues are moved to this site.